Skip to main content
. 2017 Aug 2;12(8):e0181585. doi: 10.1371/journal.pone.0181585

Fig 1. Schematic: Utilization of the KCGS.

Fig 1

(a) Disease relevant phenotypic screen highlights active compounds (b) Because all the targets are annotated, active molecules points to potential targets of interest. (c) Follow up experiments can be used to help confirm importance of these highlighted targets (d) Body of evidence implicates kinases that can be inhibited to impact disease.